Selim Medical Press

Benefit–Risk Workbench

Companion tool to Practical Benefit–Risk Assessment in Pharmacovigilance: From Safety Signals to Regulatory Decisions — Dr Hafez Selim, MD, PhD

Before you begin

This tool structures and computes. It does not conclude. Read the following, then acknowledge it.

Full terms — 15 clauses